Achieve Life Sciences ACHV Accrued compensation and employee benefits

Accrued compensation and employee benefits at other companies

Equitable HoldingsEQH

$22M-15.4%

V2XVVX

-$6.05M+85.8%

StepStone Group Inc.STEP

$202.78M+387%

Option Care Health, Inc.OPCH

-$20.98M-45.1%

FTI ConsultingFCN

-$325.02M-4.7%

Grid Dynamics Holdings, Inc.GDYN

$2.38M-57.3%

Net income-$10.2M+20.7%

EPS (diluted)-$0.19+48.6%

Cash & equivalents$28.1M+116%

Total debt$5.6M+332%

Total equity$10.7M+3.9%

Total assets$33.1M+21.0%

Operating cash flow-$6.9M+37.5%

CapEx$750.0—

Free cash flow-$12.4M—

Market cap$585.16M+404%

Enterprise value$562.71M+439%

Return on equity-496.1%-906pp

Debt / equity0.5×+0.4×

Current ratio2.6×-0.9×

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Achieve Life Sciences's accrued compensation and employee benefits?: Achieve Life Sciences (ACHV) reported accrued compensation and employee benefits of $261K in Q1 2026.
How has Achieve Life Sciences's accrued compensation and employee benefits changed year-over-year?: Achieve Life Sciences's accrued compensation and employee benefits increased by 112.6% year-over-year, from -$2.06M to $261K.